XML 39 R24.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Investments (Tables)
9 Months Ended
Dec. 31, 2019
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Investments
Investments consist of the following:
December 31,March 31,
20192019
Equity method investments in Partnerships$159,984  $122,505  
Equity method investments in Partnerships held by consolidated VIEs11,183  11,648  
Other equity method investments1,069  1,086  
Other investments16,395  12,488  
Investments valued under the measurement alternative4,537  6,764  
Total Investments$193,168  $154,491  
Reconciliation of Other Investments
The following is a reconciliation of other investments for which significant unobservable inputs (Level 3) were used in determining value:

Private equity fundsDirect credit co-investmentsDirect equity co-investmentsTotal other investments
Balance as of September 30, 2019$5,836  $3,093  $6,984  $15,913  
Contributions392  —  —  392  
Distributions(748) —  —  (748) 
Net gain457  36  345  838  
Balance as of December 31, 2019$5,937  $3,129  $7,329  $16,395  
Private equity fundsDirect credit co-investmentsDirect equity co-investmentsTotal other investments
Balance as of March 31, 2019$3,734  $3,940  $4,814  $12,488  
Contributions2,484  —  1,875  4,359  
Distributions(748) (973) —  (1,721) 
Net gain467  162  640  1,269  
Balance as of December 31, 2019$5,937  $3,129  $7,329  $16,395  
Schedule of Assumptions Used
The valuation methodologies, significant unobservable inputs, range of inputs and the weighted average input determined based upon relative fair value of the investments used in recurring Level 3 fair value measurements of assets were as follows, as of December 31, 2019:
Significant
FairValuationUnobservableWeighted
ValueMethodologyInputsRangeAverage
Private equity funds
$5,937  Adjusted net asset value  Selected market return  4.7%  -4.7%  4.7%  
Direct credit co-investments
$3,129  Recent precedent transactions  
Discounted cash flow  Market yield  9.7%  -10.1%  9.86%  
Direct equity co-investments
$7,329  Market approach  EBITDA multiple
8.0x
-
13.25x
10.87x
Market approach  Equity multiple
1.25x
1.25x